Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul 1;7(7):e2423933.
doi: 10.1001/jamanetworkopen.2024.23933.

Neonatal Sepsis Episodes and Retinopathy of Prematurity in Very Preterm Infants

Collaborators, Affiliations

Neonatal Sepsis Episodes and Retinopathy of Prematurity in Very Preterm Infants

Kirsten Glaser et al. JAMA Netw Open. .

Abstract

Importance: Retinopathy of prematurity (ROP) is a major morbidity of preterm infants causing visual impairment, including blindness, for which timely treatment is vital and prevention is key. Increasing evidence suggests that exposure to neonatal sepsis contributes to ROP development.

Objective: To investigate the association between neonatal sepsis and ROP in 2 large-scale cohorts of preterm infants born at less than 29 weeks' gestation.

Design, setting, and participants: This retrospective cohort study was conducted using data from the German Neonatal Network (GNN) and Norwegian Neonatal Network (NNN). The GNN involves 68 and the NNN includes 21 level III neonatal intensive care units. Participants were infants born at a gestation of 22 weeks and 0 days to 28 weeks and 6 days and enrolled in the GNN between January 1, 2009, and December 31, 2022, and NNN between January 1, 2009, and December 31, 2018. Data were analyzed from February through September 2023.

Exposure: Single or multiple episodes of culture-proven sepsis.

Main outcomes and measures: Any ROP and treatment-warranted ROP.

Results: Among 12 794 infants in the GNN (6043 female [47.2%] and 6751 male [52.8%]; mean [SD] gestational age, 26.4 [1.5] weeks) and 1844 infants in the NNN (866 female [47.0%] and 978 male [53.0%]; mean [SD] gestational age, 25.6 [1.5] weeks), the mean (SD) birth weight was 848 (229) g and 807 (215) g, respectively. Any ROP was present in 6370 infants (49.8%) in GNN and 620 infants (33.6%) in NNN, and treatment-warranted ROP was present in 840 infants (6.6%) in GNN and 140 infants (7.6%) in NNN. In both cohorts, there were increasing rates of treatment-warranted ROP with each sepsis episode (no sepsis: 572 of 10 658 infants [5.4%] in GNN and 85 of 1492 infants (5.7%) in NNN; 1 episode: 190 of 1738 infants in GNN [10.9%] and 29 of 293 infants [9.9%] in NNN; 2 episodes: 53 of 314 infants in GNN [16.9%] and 13 of 49 infants [26.5%] in NNN; 3 episodes: 25 of 84 infants [29.8%] in GNN and 3 of 10 infants [30.0%] in NNN). After adjusting for multiple confounders in the GNN dataset, the number of sepsis episodes was associated with ROP and treatment-warranted ROP compared with 0 episodes (1 episode: adjusted odds ratio [aOR], 1.44 [95% CI, 1.27-1.63]; P < .001 and OR, 1.60 [95% CI, 1.31-1.96]; P < .001, respectively; 2 episodes: OR, 1.81 [95% CI, 1.35-2.42]; P < .001 and OR, 2.38 [95% CI, 1.68-3.37]; P < .001, respectively; 3 episodes: OR, 4.39 [95% CI, 2.19-8.78]; P < .001 and OR, 3.88 [95% CI, 2.29-6.55]; P < .001, respectively). These associations were confirmed for any ROP by propensity score matching (for example, the aOR with propensity score matching was 1.76 [95% CI, 1.54-2.02]; P < .001 for 1 episode vs 0 episodes and 1.58 [95% CI, 1.12-2.22]; P = .007 for 3 episodes vs 0 or 1 episode). In the NNN dataset, surgical NEC was associated with treatment-warranted ROP (multivariable analysis: aOR, 3.37 [95% CI, 1.78-6.37]; P < .001).

Conclusions and relevance: This study found that in the large-scale GNN cohort, recurrent culture-proven sepsis was associated with ROP and treatment-warranted ROP in infants born at less than 29 weeks.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Klingenberg reported receiving honoraria from Chiesi outside the submitted work. Dr Herting reported receiving grants, personal fees, travel support, and speaker honoraria from Chiesi during the conduct of the study; support for other surfactant studies from Chiesi; and personal fees and speaker honoraria from Pfizer, Merck Sharp and Dohme, Sanofi, and AstraZeneca outside the submitted work; holding a patent with Chiesi for less invasive surfactant therapy; and having membership on a board of the German Research Foundation. Dr Fortmann reported receiving speaker honoraria from Chiesi and Pfizer. Dr Nentwich reported receiving speaker honoraria from Novartis. Dr Stahl reported receiving grants from Novartis, Bayer, and Roche and personal fees from Novartis, Bayer, Alcon, Apellis, and Roche outside the submitted work. Dr Göpel reported receiving personal fees from Chiesi and Abbott outside the submitted work. No other disclosures were reported.

Figures

Figure.
Figure.. Rates of Retinopathy of Prematurity (ROP) in the German Neonatal Network
The total number of infants in the respective gestational age (GA) strata and sorted by number of sepsis episodes was as follows: For infants with a GA of 22 weeks and 0 days to 24 weeks and 6 days, there were 1831 infants with 0, 588 infants with 1, 155 infants with 2, and 50 infants with 3 episodes of sepsis. For infants with a GA of 25 weeks and 0 days to 26 weeks and 6 days, there were 3776 infants with 0, 702 infants with 1, 112 infants with 2, and 28 infants with 3 episodes of sepsis. For infants with a GA of 27 weeks and 0 days to 28 weeks and 6 days, there were 5023 infants with 0, 468 infants with 1, 50 infants with 2, and 11 infants with 3 episodes of sepsis.

References

    1. Hellström A, Smith LE, Dammann O. Retinopathy of prematurity. Lancet. 2013;382(9902):1445-1457. doi:10.1016/S0140-6736(13)60178-6 - DOI - PMC - PubMed
    1. Dammann O, Hartnett ME, Stahl A. Retinopathy of prematurity. Dev Med Child Neurol. 2023;65(5):625-631. doi:10.1111/dmcn.15468 - DOI - PubMed
    1. Woods J, Biswas S. Retinopathy of prematurity: from oxygen management to molecular manipulation. Mol Cell Pediatr. 2023;10(1):12. doi:10.1186/s40348-023-00163-5 - DOI - PMC - PubMed
    1. Bahmani T, Karimi A, Rezaei N, Daliri S. Retinopathy prematurity: a systematic review and meta-analysis study based on neonatal and maternal risk factors. J Matern Fetal Neonatal Med. 2022;35(25):8032-8050. doi:10.1080/14767058.2021.1940938 - DOI - PubMed
    1. Chen ML, Guo L, Smith LE, Dammann CE, Dammann O. High or low oxygen saturation and severe retinopathy of prematurity: a meta-analysis. Pediatrics. 2010;125(6):e1483-e1492. doi:10.1542/peds.2009-2218 - DOI - PMC - PubMed

Publication types